| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |